Homberg J C, Andre C, Abuaf N
Clin Exp Immunol. 1984 Mar;55(3):561-70.
The sera of 131 patients with anti-liver-kidney microsome antibodies (anti-LKM) detected between 1973 and 1979 in two different laboratories were re-examined. (1) Eighty-six anti-LKM corresponded to the description given by Rizzetto, Swana & Doniach (1973), with a pattern of fluorescence predominating on the 3rd portion of the proximal tubules (P3). This group comprised 45 cases of idiopathic chronic hepatitis or idiopathic cirrhosis and one case of halothane-induced hepatitis. (2) Forty-five anti-LKM gave a different pattern on male mouse liver and male rat kidney: (a) fluorescence was greater on centrolobular than on periportal hepatocytes; (b) the first and second portions of proximal tubules (P1 and P2) predominated over P3; (c) P1 fluorescence was equally intense as P2 and (d) P3 cells were heterogeneous with one cell out of 20 more positive than the rest. Absorption tests confirmed that the corresponding antigen was also present in the liver microsomal fraction. A retrospective clinical study discovered tienilic acid-induced hepatitis in all cases. We suggest naming this new antibody 'anti-LKM2'.
对1973年至1979年间在两个不同实验室检测到的131例抗肝肾微粒体抗体(anti-LKM)患者的血清进行了重新检测。(1)86例anti-LKM符合Rizzetto、Swana和Doniach(1973年)给出的描述,荧光模式主要出现在近端小管的第三部分(P3)。该组包括45例特发性慢性肝炎或特发性肝硬化患者以及1例氟烷诱导的肝炎患者。(2)45例anti-LKM在雄性小鼠肝脏和雄性大鼠肾脏上呈现出不同的模式:(a)小叶中央肝细胞的荧光比门周肝细胞更强;(b)近端小管的第一和第二部分(P1和P2)比P3更明显;(c)P1荧光与P2强度相同;(d)P3细胞具有异质性,每20个细胞中有1个比其他细胞更阳性。吸收试验证实相应抗原也存在于肝微粒体部分。一项回顾性临床研究在所有病例中均发现了替尼酸诱导的肝炎。我们建议将这种新抗体命名为“anti-LKM2”。